U.S. Telecom Services and Carriers Stock News

In recent coverage, Warrior Met Coal has been highlighted as having evolved into a strong cash-generating producer of metallurgical coal for steelmakers, drawing increased interest from value and income-focused investors. This renewed attention centers on the company’s disciplined capital returns, particularly dividends and buybacks, during supportive metallurgical coal markets, which sets it apart in a volatile commodity sector. We will now explore how Warrior Met Coal’s rising profile as...

If you are wondering whether Hologic at around US$74.91 is fairly priced or offering value, you are not alone. This article walks through what the current market price might be implying. The share price has been relatively steady, with a 0.5% return over the last week, a roughly flat 30 day move at a 0.1% decline, a 0.5% return year to date, 3.1% over 1 year, and declines of 7.0% and 3.5% across the last 3 and 5 years. Recent coverage of Hologic has focused on its position in medical devices...

Key Insights The projected fair value for Kaiser Aluminum is US$133 based on 2 Stage Free Cash Flow to Equity Kaiser...

Piper Sandler recently downgraded Five9, citing slowing sub-10% growth, intensifying competition in contact-center-as-a-service, and uncertainty around AI-driven pricing models. The downgrade underscores concerns that Five9 is struggling to gain meaningful market share, particularly at the high end of the contact-center market, despite its AI ambitions. Next, we’ll examine how concerns about slowing growth and AI-related pricing uncertainty could influence Five9’s existing investment...

FMC (FMC) is back on traders’ screens after a sharp share price drop combined with a rise in short interest, a combination that is polarizing opinion on whether the stock signals risk or opportunity. See our latest analysis for FMC. The recent rebound, including a 1-day share price return of 5.39% and 1-month share price return of 11.82% to US$14.85, comes against a much weaker backdrop, with a 1-year total shareholder return decline of 69.45% and a 5-year total shareholder return decline of...

If you love investing in stocks you're bound to buy some losers. Long term Octave Specialty Group, Inc. ( NYSE:OSG...

Conference appearance puts Nutex Health (NUTX) in focus Nutex Health (NUTX) is drawing fresh attention after confirming that its top executives will present at the 2026 J.P. Morgan Healthcare Conference in San Francisco, an event closely watched by healthcare investors. See our latest analysis for Nutex Health. The upcoming J.P. Morgan appearance comes after a sharp run in Nutex Health's 90 day share price return of 67.36%, contrasted with a 3 year total shareholder return decline of 34.12%,...

Recent share price weakness in O'Reilly Automotive (ORLY), with negative returns over the past month and past 3 months, has put the auto parts retailer back on many investors’ watchlists for a closer fundamental check. See our latest analysis for O'Reilly Automotive. While the recent 30 day and 90 day share price returns of 8.6% and 10.3% declines signal fading short term momentum, O'Reilly Automotive still shows a 13% 1 year total shareholder return and a 173.7% 5 year total shareholder...

Kadant (KAI) has drawn investor attention after recent share price moves, with the stock closing at $305.11. With mixed return figures across different periods, many investors are reassessing how this industrial supplier fits their portfolios. See our latest analysis for Kadant. The recent 1-day share price return of 2.88% and 30-day share price return of 5.93% sit alongside a 1-year total shareholder return decline of 11.73%. The 3 and 5-year total shareholder returns of 62.23% and 111.29%...

Everspin Technologies, Inc. ( NASDAQ:MRAM ) shareholders would be excited to see that the share price has had a great...

In the past quarter, Alpha Wealth Insiders Fund highlighted Axon Enterprise after it reported 31% year-over-year revenue growth to US$711 million in Q3 2025 and forecast full-year revenue between US$2.55 billion and US$2.65 billion. The investor letter also underscored Axon’s push into retail, healthcare, and smart-city surveillance, building on its recurring-revenue ecosystem of devices, sensors, and AI software. We’ll now explore how this strong Q3 revenue performance and expansion into...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Vital Farms (VITL) recently saw its share price fall 6.64% on a day when the broader market gained, which has put extra attention on the company ahead of its upcoming earnings release. See our latest analysis for Vital Farms. That daily setback comes after a weaker patch, with a 7 day share price return of 9% and a 90 day share price return of 33%, while the 3 year total shareholder return of 94.37% points to stronger longer term momentum. If Vital Farms’ recent swings have you thinking about...

Jefferies Financial Group recently announced several fixed-income offerings, including new callable senior unsecured notes maturing between 2032 and 2056, alongside completed issuances totaling about US$6.72 million, while also facing an SEC probe into its First Brands exposure and preparing to report earnings. The combination of new debt issuance, regulatory scrutiny and expectations for resilient advisory and equity capital markets is reshaping how investors assess Jefferies’ balance sheet...

Wondering if Taiwan Semiconductor Manufacturing's share price still offers reasonable value after a strong run? This article walks through what the current market price might be implying. The stock last closed at US$327.43, with returns of 9.3% over 7 days, 11.1% over 30 days, 2.4% year to date and 56.5% over 1 year, while the 3 year return is very large and the 5 year return is 184.2%. Recent attention on Taiwan Semiconductor Manufacturing has largely focused on its role as a key contract...

Key Insights Given the large stake in the stock by institutions, 3D Systems' stock price might be vulnerable to their...

Alexander's (ALX) has attracted fresh attention after its recent share performance, with a 0.7% move over the past day and a 3.4% gain over the past week. This has prompted a closer look at fundamentals. See our latest analysis for Alexander's. That recent 1-day share price return of 0.7% and 7-day share price return of 3.4% sit alongside a 30-day share price return of 6.8%, a 90-day share price decline of 5.9% and a 1-year total shareholder return of 29.9%. Taken together, these figures...

Wondering if Johnson & Johnson is still a solid price for a long-term holding or if the recent run has moved it too far, too fast? This article focuses squarely on what you are getting for the price you pay. The stock last closed at US$204.79, with a 7-day return of a 1% decline, a 30-day return of 1.4%, a year-to-date return of a 1.2% decline, and a 1-year return of 44.3% that sits well above the 3-year and 5-year returns of 28.1% and 49.3%. Recent headlines around Johnson & Johnson have...

If you are wondering whether Teva Pharmaceutical Industries at around US$32.11 is offering good value today, you will want to look past the headlines and into how its current price lines up with different valuation checks. The stock has posted returns of 2.5% over the last 7 days, 12.8% over the past month, 3.7% year to date and 48.7% over the past year, with a 3 year return of 192.2% and a 5 year return of 174.0%. This naturally raises questions about what is already baked into the...

A number of Tennant Company ( NYSE:TNC ) insiders sold their shares in the last year, which may have raised concerns...

To the annoyance of some shareholders, AudioEye, Inc. ( NASDAQ:AEYE ) shares are down a considerable 25% in the last...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...